biology

List of investigational Parkinson's disease drugs

List of investigational Parkinson's disease drugs is a biology topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand List of investigational Parkinson's disease drugs rather than just read about it. In short: This is a list of investigational Parkinson's disease drugs, or drugs that are currently under development for clinical use in the treatment of Parkinson's disease but are not yet approved. They may also be referred to as investigational antiparkinsonian agents.

Key takeaways

List of investigational Parkinson's disease drugs belongs to biology; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect List of investigational Parkinson's disease drugs to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of List of investigational Parkinson's disease drugs from memory before moving on to harder problems.

Reference excerpt

This is a list of investigational Parkinson's disease drugs, or drugs that are currently under development for clinical use in the treatment of Parkinson's disease but are not yet approved. They may also be referred to as investigational antiparkinsonian agents. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in parentheses. The format of list items is "Name (Synonyms) – Mechanism of Action [Reference]". This list was last comprehensively updated in September 2025. It is likely to become outdated with time.

Under development

Preregistration AIP-201 – positron-emission tomography (PET) enhancer – diagnosis [1] Levodopa/carbidopa subcutaneous (ND-0612; ND-0680) – combination of levodopa (dopamine precursor) and carbidopa (aromatic L-amino acid decarboxylase (AAAD) inhibitor) [2]

Phase 3 Altropane (123-I Altropane; [123I]-E-IACFT; NAV-5001; O-587) – dopamine reuptake inhibitor (DRI) and single-photon emission-computed tomography (SPECT) enhancer [3] Apomorphine (Aporon) – non-selective dopamine receptor agonist and other actions [4] Apomorphine sublingual film (APL-130277; Kynmobi) – non-selective dopamine receptor agonist and other actions [5] Bemdaneprocel (BRT-DA01; DA-01; MSK-DA01; pluripotent stem cell derived dopaminergic neurons) – dopaminergic cell replacement [6] Buntanetap ((+)-(3aR)-phenserine; (+)-phenserine; ANVS-401; ANVS-405; ANVS402; posiphen) – various actions [7] 18F-LBT-999 ([18F]-LBT-999; LBT-999) – dopamine reuptake inhibitor (DRI) and positron-emission tomography (PET) enhancer – diagnosis [8] Nabilone controlled release (Nabilone FDT) – cannabinoid CB1 and CB2 receptor agonist [9] Pramipexole/rasagiline (P2B-001; rasagiline/pramipexole) – combination of pramipexole (dopamine D2-like receptor agonist) and rasagiline (MAO-B inhibitor) [10] Remlifanserin (ACP-204) – serotonin 5-HT2A receptor antagonist – Parkinson's disease psychosis [11] Solengepras (CVN-424) – G protein-coupled receptor 6 (GPR6) inhibitor [12] Tavapadon (CVL-751; PF-6649751; PF-06649751) – dopamine D1 and D5 receptor agonist [13]

Phase 2/3 BHV-8000 (TLL-041) – Janus kinase 1 inhibitor and TYK2 kinase inhibitor [14] Mesdopetam (IRL-790) – dopamine D2 and D3 receptor antagonist and other actions [15]

… excerpt ends here. Continue reading the full article.

Worked examples

Example 1 — a first encounter with List of investigational Parkinson's disease drugs

Start with the simplest possible case. Write down what List of investigational Parkinson's disease drugs claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to List of investigational Parkinson's disease drugs before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about List of investigational Parkinson's disease drugs ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of List of investigational Parkinson's disease drugs

In research: List of investigational Parkinson's disease drugs appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses List of investigational Parkinson's disease drugs in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: List of investigational Parkinson's disease drugs is common in secondary-school and first-year university syllabi. It links to neighbouring topics Antiparkinsonian agents, Lists of investigational drugs, so understanding it makes those chapters shorter.
In everyday life: Look for List of investigational Parkinson's disease drugs outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “List of investigational Parkinson's disease drugs” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study List of investigational Parkinson's disease drugs in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what List of investigational Parkinson's disease drugs means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain List of investigational Parkinson's disease drugs out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is List of investigational Parkinson's disease drugs in simple terms?

Why does List of investigational Parkinson's disease drugs matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study List of investigational Parkinson's disease drugs?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on List of investigational Parkinson's disease drugs.